ARTICLE | Company News
BioLineRx, Hebrew University of Jerusalem, Tel Aviv Sourasky Medical Center deal
November 17, 2008 8:00 AM UTC
The university's Yissum Ltd. tech transfer arm and the medical center granted BioLineRx exclusive, worldwide rights to develop and commercialize BL-5040, a leptin antagonist in preclinical developmen...